Progress and Perspective in the Treatment of Lung Cancer

Van Houtte, P. (editor); Klastersky, J. (editor); Rocmans, P. (editor)

ISBN 10: 3540625488 / ISBN 13: 9783540625483

Published by Springer, 1999

About this Item

No ownership markings; a bit of staining to rear endpapers.

Seller Inventory # 004050

Bibliographic Details

• Title: Progress and Perspective in the Treatment of Lung Cancer
• Publisher: Springer
• Publication Date: 1999
• Language: English
• ISBN 10: 3540625488
• ISBN 13: 9783540625483
• Binding: Hard Cover
• Condition: Very Good

About this title

Synopsis

Lung cancer is not a single disease process but is a group of biologically variable diseases. Therefore, accurate and complete diagnosis along with complete workup of the patient prior to decision-making in treatment is essential to devise the most appropriate treatment strategy. In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. Many prognostic indicators have been identified such as genetic markers and neuroen­ docrine differentiation, which have important roles to play in identifying the patients who would benefit most from active treatment. Screening and early detection have been thought to be sine qua non in early diagnosis of lung cancer. However, a number of controlled trials assessing the value of annual screening for lung cancer have demonstrated in some studies that chest X-rays and/or cytology screening may improve stage distribution, resectability, survival, and fatality but has not shown an impact on disease-specific mortality rates. The Mayo Clinic lung project compar­ ing quarterly chest X-rays and sputum cytology with routine care in more than 10 000 male smokers indicated that 5-year survival following treatment in the screened patients was better than rates in contemporary clinical practice. However, arguments have been ad­ vanced as to factors that might have biased the clinical benefits. Other trials are currently under way to deal with this issue along with new molecular markers that may enhance sputum sensitivity.

From the Back Cover

This volume documents the progress that has been made in the treatment of lung cancer, examining in detail the applicability and use of the various therapeutic modalities. Emphasis is placed on the benefits of a multimodality approach to lung cancer, and the editors have sought to achieve a balance between the perspectives offered by US and European authors. The comprehensive coverage of the subject and the expertise of the authors ensure that the volume will be of widest interest.